BlackRock Health Sciences Trust (BME)
| Market Value | 508.43M |
| Revenue (ttm) | 7.74M +2.2% |
| Net Income | 76.97M +228.2% |
| EPS | 5.96 +236.6% |
| Shares Out | 12.92M |
| PE Ratio | 6.61 |
| Forward PE | n/a |
| Dividend | $3.15 (7.99%) |
| Ex-Dividend Date | Apr 15, 2026 |
| Volume | 102,684 |
| Open | 39.71 |
| Previous Close | 38.67 |
| Day's Range | 39.15 - 39.71 |
| 52-Week Range | 34.18 - 42.74 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BME
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivati... [Read more]
Financial Performance
In 2025, BME's revenue was $7.74 million, an increase of 2.23% compared to the previous year's $7.57 million. Earnings were $76.97 million, an increase of 228.16%.
Financial StatementsNews
5 ‘Healthy' Dividends Paying Up To 14.1%
Healthcare dividend stocks are selling off with the turbulence in the Middle East.
7 Income-Oriented CEFs With Rising NAV And Distribution Increases For At Least 10+ Years
I highlight seven closed-end funds, or CEFs, with rising NAVs and increasing distributions over the past 10–15 years, spanning diverse asset classes. These CEFs—PEO, BDJ, BME, CSQ, UTF, STK, and GDV—o...
Never Cutters, Part 2: 5 More High-Yield CEFs That Have Never Cut The Distribution
I highlight five additional CEFs—BIT, BME, BST, BUI, and GLU—that have never cut distributions for at least a decade, offering high-yield, monthly income. BIT yields nearly 12% at a -6.8% discount, bu...
Closed-End Funds: My Top 10 Holdings February 2026
My closed-end fund portfolio update provides a more concentrated top 10, and that is on the back of a reduction in the number of holdings since last year. I remain leaning toward utility/infrastructur...
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
NEW YORK--(BUSINESS WIRE)--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), ...
Switching From THQ To BME Despite The Yield
The abrdn Healthcare Opportunities Fund has delivered strong historical returns but now faces sustainability concerns due to leverage, premium to NAV, and likely fee waiver expiration. THQ's 11% yield...
BME: Attractive Discount With Steady Monthly Distribution
BlackRock Health Sciences Trust has seen some strong performance recently, yet still trades at a -7.8% discount to NAV, offering compelling value. BME removed its options-writing strategy, eliminating...
The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners
Today I have a sweet dividend “double shot” for you: The first? A 2.8% payout set to grow thanks to AI—and take the stock price up with it.
BME: Monthly Income With Upside From The Out-Of-Favor Healthcare Sector
I rate BlackRock Health Sciences Trust a Buy for income-focused investors seeking long-term, buy-and-hold exposure to blue-chip healthcare stocks. BME trades at a -7.8% discount to NAV and offers a mo...
3 Closed-End Fund Buys In October 2025
The broader equity indexes continue to look strong, led by mega-cap tech, which has helped push the markets to all-time highs. With hitting new all-time highs, I continue to allow my cash pile to buil...
B&M shares plunge after £7M accounting error forces earnings downgrade
Shares in B&M fell more than 19% on Monday after the UK discount retailer admitted a £7 million accounting error that will hit its earnings and trigger a leadership change. The company said that overs...
BME: Attractively Valued But Weak NAV Growth
BlackRock Health Sciences Trust shares have declined 12.4% in the past year, underperforming the broader market rally. BME currently trades at an 8.3% discount to NAV, significantly wider than its fiv...
2 Call Writing Funds Providing Monthly Distributions For Passive Income
Call writing closed-end funds can offer attractive monthly distributions, along with the opportunity to trade at discounts to their historical net asset values. That discount can create an opportunity...
How To Invest $100,000 In A Near-Perfect Strategy Portfolio
Market timing is futile; a disciplined, diversified, and rules-based approach is essential for long-term investing success. A Near-Perfect Strategy portfolio aims for consistent income, growth, and lo...
BME: The Resilient Income Investment Of The Healthcare Industry
The healthcare sector is attractive due to essential nature, AI, genomics, and chronic disease management, supporting long-term growth despite regulatory and cost headwinds. BlackRock Health Sciences ...
2 Healthcare Picks For Distributions And Attractive Valuations
Healthcare CEFs are under pressure from regulatory shifts, but sector defensiveness and discounted valuations can create long-term opportunities. Within the CEF structure, we also have the added benef...
BME: Hasn't Been Dazzling, But Maybe Worth A Look Now
BlackRock Health Sciences Trust (BME), a perpetual CEF, offers a diversified portfolio of 130 health science stocks, most of which are large-caps. BME's distributions have picked up quite markedly of ...
8 Closed-End Fund Buys (And 2 Sells) In The Month Of March 2025
This month we got some increased market volatility, allowing me to put some of my cash pile to work in my closed-end fund portfolio. I also sold out of two positions, as they were starting to become o...
2 Defensive Closed-End Funds Delivering Monthly Distributions
The broader equity market has become more volatile, with mega-cap tech declines affecting the S&P 500 and Nasdaq flirting with correction territory. We are looking at two funds that provide relatively...
4 Closed-End Fund Buys (And A Sell) In The Month Of February 2025
The tech-heavy Nasdaq started to dip toward the end of February, but a strong last trading day of the month rally clawed back some of those losses. The equal-weighted S&P 500, as measured by the Inves...
BME: Questionable Distribution Coverage (Rating Downgrade)
BlackRock Health Sciences Trust has seen a 5% price decline over the past year, with a total return of 1.5% including distributions. BME's high 7.8% dividend yield is attractive but potentially unsust...
BME And FLC: There Are Still Pockets Of Opportunities
Closed-end funds have seen significant discount narrowing in 2024 across the board, as discounts have been cut in more than half on average. Despite record highs being hit regularly this year in the S...
My Top Retirement Strategy For 14% Dividends In 2025
Not many people know this, but if you really want to diversify—deftly balancing and rebalancing to maximize (and protect) your gains, you need to invest in closed-end funds (CEFs).
BME: 8.4% Yield From An Undervalued Sector
Last time around, we had rated BlackRock Health Sciences Trust as a hold. The fund has not delivered much since then, but the sector has gotten really oversold. We go over the thesis for this one toda...
11 Closed-End Fund Buys In The Month Of November 2024
This month, I've added to 11 different positions, but most of these were related to repurchases after the BlackRock tender offers. While I added to 11 different positions, these were all positions I h...